ASXL2 and myeloid neoplasm: The majority of the AML patients with somatic ASXL2 mutations are heterozygous and possess a WT allele and an ASXL2 mutant allele, which leads to nonsense/frameshift13, indicating that loss-of-function of ASXL2 might be important in the pathogenesis of myeloid malignancies.